Home > > > News

Drug Maker Shire Expands to Europe

The maker of Vyvanse has a new presence in European markets.

Monday February 23rd - 11:11am

Learn how taking a break from ADD ADHD meds affects treatment and symptoms. ADDitude Magazine

Pharmaceutical company Shire, maker of Vyvanse, has acquired rights to Equasym, a European medication used for the treatment of attention deficit hyperactivity disorder (ADD ADHD). Shire will continue to market Equasym within Europe, but it is not currently approved within the U.S. and Canada. Shire is also testing Vyvanse (now in Phase 3 trials) for approval in Europe.

Says Michael Cola, president of Shire’s Specialty Pharmaceuticals business: “Our expertise and portfolio of ADHD products will provide a strong foundation from which we can offer innovative treatments for adults and children with ADHD.”

Read more from Shire.

What do you think of this article? Share your comments on www.ADDConnect.com, ADDitude's community site. Check out the new ADHD Medication User Reviews and the ADHD Adults Support Group. Your fellow ADDers want to hear from you!

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018